4D Molecular Therapeutics Inc (FDMT) — Free Cash Flow Generation Index

Latest as of December 2025: 0.98x

4D Molecular Therapeutics Inc (FDMT) has a Free Cash Flow Generation Index of 0.98x as of December 2025. Free cash flow of $27.92 Million represents 1% of operating cash flow ($28.55 Million). Read 4D Molecular Therapeutics Inc total liabilities for a breakdown of total debt and financial obligations.

FCF Generation Index

0.98x

Free Cash Flow / Operating CF

Free Cash Flow

$27.92 Million

USD

Operating Cash Flow

$28.55 Million

USD

Capital Expenditures

$631.00K

USD

4D Molecular Therapeutics Inc Free Cash Flow Generation Index (2017–2017)

Historical FCF Generation Index trend for 4D Molecular Therapeutics Inc across 1 annual periods. Explore FDMT capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

Annual Free Cash Flow Generation for 4D Molecular Therapeutics Inc (2017–2017)

Year-by-year Free Cash Flow Generation Index for 4D Molecular Therapeutics Inc. For the full company profile including market capitalisation, see 4D Molecular Therapeutics Inc market cap and net worth.

Year	FCG Index	Free Cash Flow (USD)	Operating CF	Capital Expenditures	YoY Change
2017	0.93x	$7.66 Million	$8.24 Million	$573.00K	—

FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).